Related Experiment Videos
In vitro antibacterial activity of ceftizoxime
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|April 1, 1985
Summary
Ceftizoxime demonstrated broad-spectrum in vitro antibacterial activity against most tested bacterial strains, including Enterobacteriaceae and Gram-positive cocci. This antibiotic exhibits potent bactericidal effects, making it a promising agent for treating infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotic resistance is a growing global health concern.
- Novel antimicrobial agents are crucial for effective infection management.
- Ceftizoxime is a third-generation cephalosporin antibiotic.
Purpose of the Study:
- To evaluate the in vitro antibacterial activity of ceftizoxime.
- To determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of ceftizoxime.
- To assess the bactericidal kinetics of ceftizoxime against various bacterial pathogens.
Main Methods:
- In vitro susceptibility testing of 325 bacterial isolates.
- Determination of MIC and MBC values for ceftizoxime.
- Assessment of bacterial survival over time following antibiotic exposure.
Main Results:
- Ceftizoxime showed high sensitivity against most Enterobacteriaceae, Streptococcaceae, Micrococcaceae, Pseudomonaceae, and Acinetobacter sp. strains.
- MIC values were predominantly between 0.05-1.5 µg/ml.
- MBC/MIC ratios were typically below 4:1, indicating bactericidal activity.
- Bactericidal activity against Enterobacteriaceae was observed within 3-4 hours, with significant bacterial reduction by the first hour.
Conclusions:
- Ceftizoxime possesses significant in vitro antibacterial and bactericidal activity against a wide range of clinically relevant bacteria.
- The drug's efficacy suggests its potential utility in treating infections caused by susceptible pathogens.
- Further clinical investigation is warranted to confirm its therapeutic value.